EMC6
gene geneOn this page
Also known as MGC2963RAB5IFL
Summary
EMC6 (ER membrane protein complex subunit 6, HGNC:28430) is a protein-coding gene on chromosome 17p13.2, encoding ER membrane protein complex subunit 6 (Q9BV81). Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. It is a selective cancer dependency (DepMap: 16.7% of cell lines).
Contributes to membrane insertase activity. Involved in autophagosome assembly; protein insertion into ER membrane by stop-transfer membrane-anchor sequence; and tail-anchored membrane protein insertion into ER membrane. Located in endoplasmic reticulum membrane and omegasome membrane. Part of EMC complex.
Source: NCBI Gene 83460 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- Clinical variants (ClinVar): 14 total
- GTEx eGene: eQTL in 7 tissues, sQTL in 3 (q < 0.05)
- Cancer dependency (DepMap): dependent in 16.7% of screened cell lines
- Constraint (gnomAD): pLI 0.78 (intermediate), LOEUF 0.73 (unconstrained)
- MANE Select transcript:
NM_031298
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28430 |
| Approved symbol | EMC6 |
| Name | ER membrane protein complex subunit 6 |
| Location | 17p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC2963, RAB5IFL |
| Ensembl gene | ENSG00000127774 |
| Ensembl biotype | protein_coding |
| OMIM | 620261 |
| Entrez | 83460 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
MANE Select: ENST00000248378
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 1
ENST00000248378, ENST00000397133, ENST00000890763, ENST00000890764, ENST00001138009
RefSeq mRNA: 2 — MANE Select: NM_031298
NM_001014764, NM_031298
CCDS: CCDS11033
Canonical transcript exons
ENST00000248378 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001308926 | 3668812 | 3668899 |
| ENSE00002752197 | 3669098 | 3669665 |
Expression profiles
Bgee: expression breadth ubiquitous, 269 present calls, max score 97.22.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 78.9518 / max 375.5162, expressed in 1822 samples.
Highest expression (Bgee): hindlimb stylopod muscle, gastrocnemius, muscle of leg, muscle organ, skeletal muscle tissue of rectus abdominis.
Genetic regulation across tissues (GTEx eQTL / sQTL)
EMC6 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 7 tissues and its splicing (sQTL) in 3 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
10 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Muscle Skeletal | sqtl | 9.8e-08 | -0.73 | 17:3668945:C:T |
| Testis | eqtl | 4.5e-06 | +0.22 | 17:3676705:TG:T |
| Cells Cultured fibroblasts | sqtl | 8.8e-04 | -0.69 | 17:3668945:C:T |
| Artery Aorta | eqtl | 1.9e-03 | -0.25 | 17:3134805:G:T |
| Nerve Tibial | sqtl | 7.3e-03 | -0.36 | 17:3350291:C:T |
| Skin Not Sun Exposed Suprapubic | eqtl | 3.6e-02 | -0.19 | 17:3491475:G:A |
| Colon Transverse | eqtl | 3.6e-02 | -0.10 | 17:3726573:G:A |
| Esophagus Muscularis | eqtl | 4.4e-02 | -0.28 | 17:3057465:C:T |
| Cells Cultured fibroblasts | eqtl | 4.8e-02 | -0.20 | 17:3161431:A:G |
| Brain Spinal cord cervical c-1 | eqtl | 5.0e-02 | -0.68 | 17:3004868:G:A |
FANTOM5 promoters
1 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 158879 | 78.9518 | 1822 |
Top tissues by expression
showing 100 of 282 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 97.22 | gold quality |
| gastrocnemius | UBERON:0001388 | 97.21 | gold quality |
| muscle of leg | UBERON:0001383 | 96.61 | gold quality |
| muscle organ | UBERON:0001630 | 96.22 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 95.84 | gold quality |
| apex of heart | UBERON:0002098 | 95.60 | gold quality |
| vastus lateralis | UBERON:0001379 | 95.43 | silver quality |
| quadriceps femoris | UBERON:0001377 | 95.39 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.29 | gold quality |
| cardiac ventricle | UBERON:0002082 | 95.20 | gold quality |
| diaphragm | UBERON:0001103 | 95.17 | silver quality |
| biceps brachii | UBERON:0001507 | 95.01 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 94.79 | gold quality |
| right testis | UBERON:0004534 | 94.73 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.64 | gold quality |
| deltoid | UBERON:0001476 | 94.57 | silver quality |
| triceps brachii | UBERON:0001509 | 94.56 | gold quality |
| gluteal muscle | UBERON:0002000 | 94.53 | gold quality |
| left testis | UBERON:0004533 | 94.52 | gold quality |
| heart right ventricle | UBERON:0002080 | 94.42 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.37 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 94.33 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.24 | gold quality |
| adult organism | UBERON:0007023 | 93.99 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.92 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.90 | gold quality |
| cardiac atrium | UBERON:0002081 | 93.81 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.78 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.61 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.54 | gold quality |
| heart | UBERON:0000948 | 93.52 | gold quality |
| right lobe of liver | UBERON:0001114 | 93.27 | gold quality |
| body of tongue | UBERON:0011876 | 93.22 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.05 | gold quality |
| body of stomach | UBERON:0001161 | 93.04 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 93.00 | gold quality |
| testis | UBERON:0000473 | 92.76 | gold quality |
| muscle tissue | UBERON:0002385 | 92.74 | gold quality |
| granulocyte | CL:0000094 | 92.55 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 92.27 | gold quality |
| lower esophagus | UBERON:0013473 | 92.22 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 92.22 | gold quality |
| esophagus mucosa | UBERON:0002469 | 92.13 | gold quality |
| tibialis anterior | UBERON:0001385 | 92.05 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 91.86 | gold quality |
| esophagus | UBERON:0001043 | 91.78 | gold quality |
| putamen | UBERON:0001874 | 91.59 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 91.54 | gold quality |
| spinal cord | UBERON:0002240 | 91.37 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 91.35 | gold quality |
| cingulate cortex | UBERON:0003027 | 91.33 | gold quality |
| nephron tubule | UBERON:0001231 | 91.30 | silver quality |
| transverse colon | UBERON:0001157 | 91.27 | gold quality |
| metanephros cortex | UBERON:0010533 | 91.25 | gold quality |
| adrenal gland | UBERON:0002369 | 91.22 | gold quality |
| amygdala | UBERON:0001876 | 91.11 | gold quality |
| gingival epithelium | UBERON:0001949 | 91.11 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 91.10 | gold quality |
| monocyte | CL:0000576 | 91.07 | gold quality |
| leukocyte | CL:0000738 | 91.00 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 90.97 | gold quality |
| caudate nucleus | UBERON:0001873 | 90.94 | gold quality |
| mononuclear cell | CL:0000842 | 90.91 | gold quality |
| prefrontal cortex | UBERON:0000451 | 90.83 | gold quality |
| right frontal lobe | UBERON:0002810 | 90.75 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 90.61 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 90.54 | gold quality |
| cortex of kidney | UBERON:0001225 | 90.53 | gold quality |
| tongue | UBERON:0001723 | 90.50 | gold quality |
| metanephros | UBERON:0000081 | 90.43 | gold quality |
| ventricular zone | UBERON:0003053 | 90.31 | gold quality |
| nucleus accumbens | UBERON:0001882 | 90.26 | gold quality |
| left coronary artery | UBERON:0001626 | 90.22 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 90.21 | gold quality |
| body of pancreas | UBERON:0001150 | 90.13 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 90.13 | silver quality |
| gingiva | UBERON:0001828 | 90.10 | silver quality |
| small intestine Peyer’s patch | UBERON:0003454 | 90.02 | gold quality |
| omental fat pad | UBERON:0010414 | 90.00 | gold quality |
| peritoneum | UBERON:0002358 | 89.99 | gold quality |
| colon | UBERON:0001155 | 89.93 | gold quality |
| skin of abdomen | UBERON:0001416 | 89.88 | gold quality |
| minor salivary gland | UBERON:0001830 | 89.86 | gold quality |
| coronary artery | UBERON:0001621 | 89.83 | gold quality |
| renal glomerulus | UBERON:0000074 | 89.81 | silver quality |
| large intestine | UBERON:0000059 | 89.80 | gold quality |
| fundus of stomach | UBERON:0001160 | 89.77 | gold quality |
| mucosa of stomach | UBERON:0001199 | 89.76 | gold quality |
| stomach | UBERON:0000945 | 89.75 | gold quality |
| mouth mucosa | UBERON:0003729 | 89.74 | gold quality |
| right coronary artery | UBERON:0001625 | 89.71 | gold quality |
| left uterine tube | UBERON:0001303 | 89.70 | gold quality |
| neocortex | UBERON:0001950 | 89.69 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.61 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 89.60 | gold quality |
| skin of leg | UBERON:0001511 | 89.42 | gold quality |
| frontal cortex | UBERON:0001870 | 89.42 | gold quality |
| substantia nigra | UBERON:0002038 | 89.42 | gold quality |
| spleen | UBERON:0002106 | 89.41 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 89.34 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.07 |
HPA expression
RNA tissue specificity: Tissue enhanced
showing 60 of 77 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Skeletal muscle | tissue | 132.6 | not detected |
| Thalamus | tissue | 71.5 | |
| Pons | tissue | 70.2 | |
| Superior colliculi | tissue | 70.0 | |
| Cerebral cortex | tissue | 68.1 | low |
| Somatosensory cortex | tissue | 68.1 | |
| Midbrain | tissue | 63.6 | |
| Hippocampal formation | tissue | 59.6 | |
| Medulla oblongata | tissue | 59.2 | |
| Occipital cortex | tissue | 57.5 | |
| Motor cortex | tissue | 56.5 | |
| Tongue | tissue | 56.5 | |
| Cerebellum | tissue | 56.4 | not detected |
| Putamen | tissue | 55.9 | |
| Spinal cord | tissue | 55.7 | |
| Entorhinal cortex | tissue | 55.0 | |
| Substantia nigra | tissue | 54.1 | |
| Hypothalamus | tissue | 53.0 | |
| Temporal cortex | tissue | 52.9 | |
| Retrosplenial and cingulate cortex | tissue | 52.4 | |
| Septum | tissue | 52.1 | |
| Prefrontal cortex | tissue | 50.9 | |
| Basal ganglia | tissue | 50.2 | not detected |
| Retrosplenial cortex | tissue | 49.6 | |
| Ventral forebrain | tissue | 48.5 | |
| Periaqueductal gray | tissue | 46.2 | |
| Corpus callosum | tissue | 44.3 | |
| Amygdala | tissue | 43.8 | |
| Insular cortex | tissue | 43.7 | |
| Frontal cortex | tissue | 42.0 | |
| Olfactory bulb | tissue | 37.7 | |
| Caudate putamen | tissue | 37.3 | |
| Choroid plexus | tissue | 32.2 | |
| Vagina | tissue | 28.9 | not detected |
| Bone marrow | tissue | 28.7 | low |
| Pituitary gland | tissue | 26.8 | |
| Liver | tissue | 23.8 | not detected |
| Heart muscle | tissue | 23.0 | medium |
| Stomach 1 | tissue | 21.9 | medium |
| Locus coeruleus | tissue | 21.6 | |
| Hippocampus | tissue | 20.8 | low |
| Nucleus accumbens | tissue | 19.8 | |
| Testis | tissue | 19.1 | medium |
| Duodenum | tissue | 18.8 | low |
| Postcentral gyrus | tissue | 18.8 | |
| Salivary gland | tissue | 18.5 | not detected |
| Pancreas | tissue | 18.2 | low |
| Small intestine | tissue | 17.9 | medium |
| Colon | tissue | 17.7 | medium |
| Parathyroid gland | tissue | 17.4 | not detected |
| Kidney | tissue | 17.4 | medium |
| Adipose tissue | tissue | 16.7 | not detected |
| Retina | tissue | 16.0 | |
| Adrenal gland | tissue | 15.5 | low |
| Thymus | tissue | 14.5 | |
| Urinary bladder | tissue | 13.8 | low |
| Appendix | tissue | 13.8 | medium |
| Prostate | tissue | 13.5 | not detected |
| Spleen | tissue | 13.1 | not detected |
| Breast | tissue | 12.7 | not detected |
Brain sub-regions (HPA Brain Atlas): detected in 191; highest nTPM — Dorsal hippocampus (59.6), Ventral spinal cord (55.7), Dorsal spinal cord (52.4), Ventral hippocampus (51.5), Subiculum (47.4).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting EMC6 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
20 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-589-3P | 99.91 | 69.62 | 2088 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-5100 | 99.11 | 67.52 | 1098 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-29B-1-5P | 98.86 | 68.35 | 1364 |
| HSA-MIR-4511 | 98.32 | 67.97 | 1500 |
| HSA-MIR-3155A | 98.16 | 66.09 | 965 |
| HSA-MIR-3155B | 98.16 | 66.09 | 965 |
| HSA-MIR-484 | 98.16 | 66.92 | 1074 |
| HSA-MIR-4438 | 97.96 | 63.70 | 947 |
| HSA-MIR-503-5P | 97.87 | 66.83 | 575 |
| HSA-MIR-1255B-2-3P | 97.80 | 67.04 | 880 |
| HSA-MIR-4521 | 97.73 | 67.64 | 684 |
| HSA-MIR-4694-5P | 94.62 | 65.39 | 532 |
Functional genomics
gnomAD constraint: pLI 0.778, LOEUF 0.734, missense Z 0.984 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000248378 — one region, missense o/e 0.78.
DepMap (CRISPR cell-line fitness): dependent in 16.7% of screened cell lines.
Most-dependent cell lines (DepMap gene-effect, lower = stronger; ≤ −0.5 shown): EJM (-1.533), ONE58 (-1.416), WSU-NHL (-1.402), UPMD1 (-1.284), BHT-101 (-1.283), C8166 (-1.221), MEC-1 (-1.215), SKNO-1 (-1.212), NB-4 (-1.211), 647-V (-1.186), THP-1 (-1.178), UM-RC-3 (-1.17), SCCOHT-1 (-1.164), OCI-LY18 (-1.133), Hs 944.T (-1.131).
Literature-anchored findings (GeneRIF, showing 6)
- Endoplasmic membrane protein complex subunit 6 (EMC6) interacted with both RAB5A and BECN1/Beclin 1 and colocalized with the omegasome marker ZFYVE1/DFCP1. (PMID:23182941)
- This is the first study to show that EMC6 induces cell death in gastric cancer cells. The molecular mechanism of how EMC6 functions as a tumor suppressor needs to be further explored. (PMID:28648145)
- The expression level of EMC-6 is significantly elevated in cervical cancer, without significant correlation with Beclin1 and Rab5a. (PMID:28742203)
- Adenovirus-mediated ectopic overexpression of EMC6 (Ad5-EMC6) decreases the activity of ERK1/2, down-regulates the levels of BCL-2 and increases the ratio of BAX/BCL-2. Ad5-EMC6 mediates anti-tumor activity through the mitochondrial apoptosis pathway. Ad5-EMC6 enhances the sensitivity of gastric cancer cells to the etoposide. (PMID:30982575)
- EMC6 regulates acinar apoptosis via APAF1 in acute and chronic pancreatitis. (PMID:33177505)
- Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression. (PMID:38445807)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | emc6 | ENSDARG00000035282 |
| mus_musculus | Emc6 | ENSMUSG00000047260 |
| rattus_norvegicus | Emc6 | ENSRNOG00000019352 |
| drosophila_melanogaster | EMC6 | FBGN0039259 |
| caenorhabditis_elegans | WBGENE00017999 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1913298) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 4 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| increased hematocrit | 1 |
| preweaning lethality, complete penetrance | 1 |
| embryonic lethality prior to organogenesis | 1 |
| embryonic lethality prior to tooth bud stage | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q3ZCG8 | 98.2% | Diamond |
| Xenopus laevis | Q68EU8 | 98.2% | Diamond |
| Xenopus tropicalis | Q6GLC5 | 98.2% | Diamond |
| Dictyostelium discoideum | Q1ZXH4 | 37.0% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| P2RX5-TAX1BP3 | ncRNA | 100533970 |
| CTNS | protein-coding | 1497 |
| SHPK | protein-coding | 23729 |
| TAX1BP3 | protein-coding | 30851 |
| ITGAE | protein-coding | 3682 |
| P2RX5 | protein-coding | 5026 |
| NCBP3 | protein-coding | 55421 |
| HASPIN | protein-coding | 83903 |
| TRPV1 | protein-coding | 7442 |
Protein
Protein identifiers
ER membrane protein complex subunit 6 — Q9BV81 (reviewed: Q9BV81)
Alternative names: Transmembrane protein 93
All UniProt accessions (1): Q9BV81
UniProt curated annotations — full annotation on UniProt →
Function. Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Preferentially accommodates proteins with transmembrane domains that are weakly hydrophobic or contain destabilizing features such as charged and aromatic residues. Involved in the cotranslational insertion of multi-pass membrane proteins in which stop-transfer membrane-anchor sequences become ER membrane spanning helices. It is also required for the post-translational insertion of tail-anchored/TA proteins in endoplasmic reticulum membranes. By mediating the proper cotranslational insertion of N-terminal transmembrane domains in an N-exo topology, with translocated N-terminus in the lumen of the ER, controls the topology of multi-pass membrane proteins like the G protein-coupled receptors. By regulating the insertion of various proteins in membranes, it is indirectly involved in many cellular processes.
Subunit / interactions. Component of the ER membrane protein complex (EMC).
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the EMC6 family.
RefSeq proteins (2): NP_001014764, NP_112588* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008504 | Emc6 | Family |
| IPR029008 | EMC6-like | Family |
Pfam: PF07019
UniProt features (19 total): helix 6, topological domain 4, transmembrane region 3, mutagenesis site 2, initiator methionine 1, chain 1, strand 1, modified residue 1
Structure
Experimental structures (PDB)
10 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 8J0O | cryo-EM structure of human EMC and VDAC | ELECTRON MICROSCOPY | 3.32 |
| 7ADO | Cryo-EM structure of human ER membrane protein complex in lipid nanodiscs | ELECTRON MICROSCOPY | 3.39 |
| 6WW7 | Structure of the human ER membrane protein complex in a lipid nanodisc | ELECTRON MICROSCOPY | 3.4 |
| 8EOI | Structure of a human EMC:human Cav1.2 channel complex in GDN detergent | ELECTRON MICROSCOPY | 3.4 |
| 8J0N | cryo-EM structure of human EMC | ELECTRON MICROSCOPY | 3.47 |
| 7ADP | Cryo-EM structure of human ER membrane protein complex in GDN detergent | ELECTRON MICROSCOPY | 3.6 |
| 8S9S | Structure of the human ER membrane protein complex (EMC) in GDN | ELECTRON MICROSCOPY | 3.6 |
| 9ZZ6 | The ER membrane protein complex acts as a chaperone to promote voltage-gated calcium … | ELECTRON MICROSCOPY | 4.16 |
| 6Z3W | Human ER membrane protein complex | ELECTRON MICROSCOPY | 6.4 |
| 9C7V | Structure of the human BOS:human EMC complex in GDN | ELECTRON MICROSCOPY | 6.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BV81-F1 | 82.32 | 0.46 |
Human Protein Atlas
Protein class: Transporters, Primary Active Transporters, Predicted membrane proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): centrosome; nucleoplasm
Antibody reliability (HPA): IH uncertain · IF approved
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1)
| Type | Positions |
|---|---|
| N-acetylalanine | 2 |
Mutagenesis-validated functional residues (2)
| Position | Phenotype |
|---|---|
| 27 | no effect on emc assembly but decreased membrane insertion of hydrophobic transmembrane helices-containing proteins by the emc. |
| 31 | no effect on emc assembly but decreased membrane insertion of hydrophobic transmembrane helices-containing proteins by the emc. |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 138 (showing top):
TSENG_IRS1_TARGETS_UP, GOBP_VACUOLE_ORGANIZATION, PAL_PRMT5_TARGETS_UP, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GGGTGGRR_PAX4_03, YY1_Q6, GOBP_MACROAUTOPHAGY, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOBP_ORGANELLE_ASSEMBLY, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_MEMBRANE_ORGANIZATION, GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION, GOBP_LOCALIZATION_WITHIN_MEMBRANE
GO Biological Process (3): autophagosome assembly (GO:0000045), protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050), tail-anchored membrane protein insertion into ER membrane (GO:0071816)
GO Molecular Function (2): protein binding (GO:0005515), membrane insertase activity (GO:0032977)
GO Cellular Component (5): endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), EMC complex (GO:0072546), omegasome membrane (GO:1903349), endoplasmic reticulum (GO:0005783)
GO top-level categories
23 GO namespaces:
| Category | Terms |
|---|---|
| protein insertion into ER membrane | 2 |
| Atg12 activating enzyme activity | 1 |
| protein-phosphatidylethanolamide deconjugating activity | 1 |
| Atg12 conjugating enzyme activity | 1 |
| Atg12 ligase activity | 1 |
| organelle assembly | 1 |
| Atg1/ULK1 kinase complex assembly | 1 |
| autophagosome organization | 1 |
| binding | 1 |
| establishment of protein localization to membrane | 1 |
| protein carrier activity | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
| endoplasmic reticulum membrane | 1 |
| membrane protein complex | 1 |
| endoplasmic reticulum protein-containing complex | 1 |
| bounding membrane of organelle | 1 |
| omegasome | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 7 of 10 annotations. The rest are phylogenetic / computational / electronic (IEA).
7 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| autophagosome assembly | BP | mutant phenotype |
| protein insertion into ER membrane by stop-transfer membrane-anchor sequence | BP | direct assay |
| tail-anchored membrane protein insertion into ER membrane | BP | direct assay |
| EMC complex | CC | direct assay |
| endoplasmic reticulum membrane | CC | direct assay |
| membrane | CC | direct assay |
| omegasome membrane | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 1,480 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EMC6 | MMGT1 | Q8N4V1 | 850 |
| EMC6 | EMC3 | Q9P0I2 | 848 |
| EMC6 | EMC4 | Q5J8M3 | 842 |
| EMC6 | EMC1 | Q8N766 | 836 |
| EMC6 | EMC2 | Q15006 | 814 |
| EMC6 | EMC8 | O43402 | 786 |
| EMC6 | EMC7 | Q9NPA0 | 779 |
| EMC6 | EMC9 | Q9Y3B6 | 768 |
| EMC6 | EMC10 | Q5UCC4 | 766 |
| EMC6 | OXA1L | Q15070 | 646 |
| EMC6 | GET1 | O00258 | 640 |
| EMC6 | TMCO1 | Q9UM00 | 587 |
| EMC6 | GET3 | O43681 | 548 |
| EMC6 | SEC61A1 | P38378 | 547 |
| EMC6 | CAMLG | P49069 | 495 |
IntAct
Human interaction partners of EMC6 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
18 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| MMGT1 | physical association | 0.810 | 4 |
| AQP6 | physical association | 0.560 | 3 |
| AQP9 | physical association | 0.560 | 3 |
| CD79A | physical association | 0.560 | 3 |
| EBP | physical association | 0.560 | 3 |
| ERGIC3 | physical association | 0.560 | 3 |
| FAM209A | physical association | 0.560 | 3 |
| MFSD14B | physical association | 0.560 | 3 |
| MMD | physical association | 0.560 | 3 |
| MUC1 | physical association | 0.560 | 3 |
| PDZK1IP1 | physical association | 0.560 | 3 |
| SLC10A6 | physical association | 0.560 | 3 |
| SLC39A2 | physical association | 0.560 | 3 |
| SLC7A1 | physical association | 0.560 | 3 |
| TLCD4 | physical association | 0.560 | 3 |
| TMEM14B | physical association | 0.560 | 3 |
| TMEM237 | physical association | 0.560 | 3 |
| EMC8 | association | 0.530 | 2 |
BioGRID (100 interactions; top human partners by supporting records): EMC2 (Affinity Capture-MS; 4 records), MMGT1 (Affinity Capture-MS; 4 records), EMC7 (Affinity Capture-MS; 3 records), EMC3 (Affinity Capture-MS; 2 records), EMC8 (Affinity Capture-MS; 2 records), EMC9 (Affinity Capture-MS; 2 records), HLA-DRB1 (Affinity Capture-MS; 2 records), RNF149 (Affinity Capture-MS; 2 records), TMEM237 (Proximity Label-MS; 2 records), AQP6 (Two-hybrid), AQP9 (Two-hybrid), ATP6AP1 (Negative Genetic), C4orf32 (Affinity Capture-MS), CCDC47 (Affinity Capture-MS), CD79A (Two-hybrid)
SIGNOR signaling
2 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| EMC6 | “form complex” | “Endoplasmic reticulum membrane complex- EMC9 variant” | binding |
| EMC6 | “form complex” | “Endoplasmic reticulum membrane complex, EMC8 variant” | binding |
Protein complexes (CORUM) (2)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
2 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| ER membrane protein complex (EMC8) | 9 | EMC6, MMGT1, EMC1, EMC10, EMC2, EMC3, EMC4, EMC7, EMC8 |
| ER membrane protein complex (EMC9) | 9 | EMC4, EMC6, EMC9, MMGT1, EMC1, EMC10, EMC2, EMC7, EMC3 |
Disease & clinical
Genetic variants
Variant evidence for EMC6: 14 ClinVar records (0 pathogenic / likely pathogenic).
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 13 |
| Likely benign | 0 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 23 predictions of 64):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 17:3668870 | donor_gain | 0.9900 | |
| 17:3669002 | donor_gain | 0.9700 | |
| 17:3669096–3669097 | acceptor_loss | 0.9700 | 6 |
| 17:3668900–3668901 | donor_loss | 0.9500 | 5 |
| 17:3668901 | donor_loss | 0.9400 | |
| 17:3669013–3669014 | donor_loss | 0.9300 | 4 |
| 17:3669019 | donor_gain | 0.9300 | |
| 17:3669013–3669014 | donor_loss | 0.9200 | 2 |
| 17:3668984 | donor_gain | 0.9100 | |
| 17:3669012 | donor_loss | 0.9100 |
AlphaMissense
350 missense substitutions predicted likely pathogenic (of 681 scored), across 86 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| N22 | 8 | 0.951 | 0.988 |
| F102 | 8 | 0.943 | 0.986 |
| H108 | 8 | 0.938 | 0.986 |
| F78 | 8 | 0.883 | 0.980 |
| F54 | 8 | 0.868 | 0.969 |
| F52 | 8 | 0.865 | 0.964 |
| W100 | 7 | 0.983 | 0.997 |
| M106 | 7 | 0.882 | 0.987 |
| F99 | 7 | 0.879 | 0.974 |
| W74 | 7 | 0.851 | 0.967 |
| F94 | 7 | 0.822 | 0.922 |
| G38 | 6 | 0.991 | 0.999 |
| G42 | 6 | 0.990 | 0.998 |
| G51 | 6 | 0.982 | 0.996 |
| G45 | 6 | 0.963 | 0.990 |
| G105 | 6 | 0.958 | 0.996 |
| V107 | 6 | 0.931 | 0.983 |
| T101 | 6 | 0.900 | 0.982 |
| T95 | 6 | 0.854 | 0.979 |
| T31 | 6 | 0.726 | 0.797 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Lung Adenocarcinoma (TCGA) | unfavorable | 1.44e-05 |
Disease associations
OMIM: gene MIM:620261 | disease phenotypes:
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| mono-(2-ethylhexyl)phthalate | decreases methylation, increases abundance | 1 |
| sodium arsenite | increases expression, increases abundance | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| abrine | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases methylation, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Vitamin E | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1R4 | Abcam HeLa EMC6 KO | Cancer cell line | Female |
| CVCL_SL93 | HAP1 EMC6 (-) 1 | Cancer cell line | Male |
| CVCL_SL94 | HAP1 EMC6 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.